By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytoSorbents, Inc. 

7 Deer Park Drive
Suite K
Monmouth Junction  New Jersey  08852  U.S.A.
Phone: 732-329-8885 Fax: 732-329-8650


CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb is CE Mark certified and is currently distributed in 37 countries around the world as a safe and effective extracorporeal cytokine adsorber, designed to reduce the “cytokine storm” or “cytokine release syndrome” that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis, as well as in cancer immunotherapy.


February 2012


Founders: Christian Steiner and Phillip Chan

CEO: Phillip Chan


Please click here for CytoSorbents job opportunities.


Key Statistics

Ownership: Private

Web Site: CytoSorbents

Medical Device

Company News
CytoSorbents Awarded $719,000 Grant To Acutely Stabilize Severe Burn Patients 8/14/2017 7:19:54 AM
CytoSorbents Reports Record Quarterly Total Revenue and Product Sales In The Second Quarter 2017 8/8/2017 12:12:28 PM
Why CytoSorbents And Spectral Medical (EDTXF) Are Not Good Stocks For A Long Position 8/4/2017 6:32:50 AM
CytoSorbents To Report Q2 2017 Operating and Financial Results 8/1/2017 2:08:22 PM
CytoSorbents Expands Distribution And Sales of CytoSorb To Treat Deadly Inflammation In Panama With DRGR 7/17/2017 8:57:35 AM
CytoSorbents Awarded $1 Million STTR Phase II Contract To Advance Development of Life-Saving Universal Plasma 7/13/2017 6:46:14 AM
CytoSorbents Receives Additional $5 Million in Non-Dilutive Debt Financing From Bridge Bank 7/5/2017 9:08:17 AM
CytoSorbents Announces Director And Management Open Market Stock Purchases 6/15/2017 8:28:48 AM
Dr. Eric G. Mortensen, M.D., Ph.D., Clinical Trial Veteran, Joins CytoSorbents As Chief Medical Officer 5/30/2017 6:43:00 AM
CytoSorbents Reports First Quarter 2017 Financial Results 5/9/2017 10:53:27 AM